Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

Research Examining Factors Associated with the Opioid Crisis among Underserved African Americans (REFOCUS)

Award Number: R01DA049333
ORGANIZATION: NATIONAL INSTITUTE ON DRUG ABUSE
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 09/30/2020
PERIOD OF PERFORMANCE END DATE: 07/31/2026

Group Awards By:

View Award Description

Research Examining Factors Associated with the Opioid Crisis among Underserved African Americans (REFOCUS) - ABSTRACT Opioid-related overdose rates among African Americans have increased exponentially. Given African American opioid users have the lowest treatment completion rates when compared to other races/ethnicities there is increased risk for mortality and morbidity. As a result, there is a dire need to better understand this fatal epidemic among this historically underserved group. Using the theory of Subcultural Evolution and Drug Use which suggests cultural and generational influences are linked to drug use patterns and risks among African Americans, the Research Examining Factors Associated with the Opioid Crisis among Underserved African Americans (REFOCUS) project will employ a within-racial group, mixed-methods design among African American adults in the community. The overall objective is to better understand the complex structural, social, and cultural factors that differentially influence NMPOU, other nonmedical prescription drug use and treatment service use among African Americans. Ultimately, our goal is to gather data that will inform culturally-tailored interventions to reduce NMPOU and better facilitate initiation and completion of treatment. The REFOCUS project has three aims: 1) To understand cultural and generational characteristics associated with NMPOU, other NMPDU, illicit drug use and treatment service use. We will conduct in-depth interviews with approximately 40 African American nonmedical prescription opioid users stratified by gender and age to understand NMPOU across the lifespan within the context of lived experience. Using thematic analysis, data will be gathered to culturally-tailor the survey. 2) To assess structural, social and cultural patterns of NMPOU, other NMPDU, illicit drug use and treatment service use among 800 (400 = male and 400 = female) African American NMPO users. We will conduct cross-sectional face-to-face culturally-informed surveys (modified by information obtained in Aim 1) and drug testing using targeted recruitment and stratified sampling by age and gender. 3) To pretest messaging generated from initial findings that will inform targeted interventions specific to African American nonmedical prescription opioid users. We will conduct in-depth, semi-structured interviews and using health communication techniques, we will develop a library of cultural, gender, and generational specific messages related to decreasing NMPOU and increasing treatment engagement and retention. We will test these messages that will be constructed from Aim 1 and Aim 2 data with approximately 40 African American nonmedical prescription opioid users stratified by gender and age. This pretesting task will prepare us to conduct a fully powered RCT as the next step in our research. This underrepresented new investigator led project directly aligns with the PAR and NIDA’s priority focus area of “addressing real-world complexities”. As this high-impact project focuses on a marginalized group underrepresented in opioid use research and it has the potential to yield insights on ways to culturally-tailor future interventions for African Americans.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2027 ( Subtotal = -$5,216 )
2027	2024	UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE	500 S LIMESTONE	LEXINGTON	KY	40526	FAYETTE	USA	Drug Use and Addiction Research Programs	000	5	10/26/2026	NON-COMPETING CONTINUATION	-$5,216
														Subtotal = -$5,216

Issue Date FY: 2024 ( Subtotal = $621,634 )
2024	2024	UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE	500 S LIMESTONE	LEXINGTON	KY	40526	FAYETTE	USA	Drug Use and Addiction Research Programs	000	5	7/26/2024	NON-COMPETING CONTINUATION	$621,634
														Subtotal = $621,634

Issue Date FY: 2023 ( Subtotal = $635,920 )
2023	2023	UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE	500 S LIMESTONE 109 KINKEAD HALL	LEXINGTON	KY	40526	FAYETTE	USA	Drug Use and Addiction Research Programs	000	4	7/6/2023	NON-COMPETING CONTINUATION	$635,920
														Subtotal = $635,920

Issue Date FY: 2022 ( Subtotal = $635,112 )
2022	2022	UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE	500 S LIMESTONE 109 KINKEAD HALL	LEXINGTON	KY	40526	FAYETTE	USA	Drug Use and Addiction Research Programs	000	3	7/20/2022	NON-COMPETING CONTINUATION	$635,112
														Subtotal = $635,112

Issue Date FY: 2021 ( Subtotal = $652,415 )
2021	2021	UNIVERSITY OF KENTUCKY	500 S LIMESTONE 109 KINKEAD HALL	LEXINGTON	KY	40526	FAYETTE	USA	Drug Use and Addiction Research Programs	000	2	6/18/2021	NON-COMPETING CONTINUATION	$652,415
														Subtotal = $652,415

Issue Date FY: 2020 ( Subtotal = $661,701 )
2020	2020	UNIVERSITY OF KENTUCKY	500 S LIMESTONE 109 KINKEAD HALL	LEXINGTON	KY	40526	FAYETTE	USA	Drug Use and Addiction Research Programs	000	1	9/18/2020	NEW	$661,701
														Subtotal = $661,701

Grand Total All Awards = $3,201,566

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Research Examining Factors Associated with the Opioid Crisis among Underserved African Americans (REFOCUS)

Award Number: R01DA049333

ORGANIZATION: NATIONAL INSTITUTE ON DRUG ABUSE

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 09/30/2020

PERIOD OF PERFORMANCE END DATE: 07/31/2026

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer